Hisamitsu Pharmaceutical Co., Inc.
$4.55+140215.30%(+$4.55)
TickerSpark Score
67/100
84
Valuation
85
Profitability
35
Growth
100
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HTSUY research report →
52-Week Range0% of range
Low $4.55
Current $4.55
High $9.42
Companywww.hisamitsu.co.jp
Hisamitsu Pharmaceutical Co. , Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products.
- CEO
- Kazuhide Nakatomi
- IPO
- 2017
- Employees
- 2,769
- HQ
- Tosu, JP
Price Chart
-32.59% · this period
Valuation
- Market Cap
- $1.28B
- P/E
- 22.30
- P/S
- 2.61
- P/B
- 1.46
- EV/EBITDA
- 13.58
- Div Yield
- 1.99%
Profitability
- Gross Margin
- 58.96%
- Op Margin
- 10.99%
- Net Margin
- 11.75%
- ROE
- 6.99%
- ROIC
- 4.66%
Growth & Income
- Revenue
- $1.09B · 6.32%
- Net Income
- $127.84M · -10.40%
- EPS
- $0.45 · -6.25%
- Op Income
- $119.55M
- FCF YoY
- 87.81%
Performance & Tape
- 52W High
- $9.42
- 52W Low
- $4.55
- 50D MA
- $6.65
- 200D MA
- $6.74
- Beta
- 0.04
- Avg Volume
- 4
Get TickerSpark's AI analysis on HTSUY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HTSUY Coverage
We haven't published any research on HTSUY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HTSUY Report →